|
|
Post by trondisc on Sept 23, 2016 10:22:57 GMT -5
Fellow Longs, today marks the day we should all face the facts...MannKind is done. Since August 2015 I believed (& bought; ultimately I've lost -$35k+) Afrezza/Technosphere could improve patients lives and change modern medicine. Unfortunately no amount of good news (the script uptrend, that supposed MLB advertising bullsh*t which will not happen, the stellar ADA+JDRF reviews, etc) can save this company. It is too little to late especially with the staggering & unrelenting short position. Liane can edit & delete posts hiding the scary truth: management squandered a golden opportunity, failed patients and screwed shareholders forever. Only a miracle like Novo Nordisk could save MannKind now and we all know that is not happening. This is a tragic damn shame how this story ended: PWD around the world will never discover the benefits of Afrezza. Big bio-pharma buried disruptive innovation and shorts have won.
|
|
|
|
Post by kbrion77 on Sept 23, 2016 10:27:39 GMT -5
This thread will go over real well.
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Sept 23, 2016 10:28:07 GMT -5
did you sell your 100% position today? if so good luck on your next journey.
I guess the script growth disappointed you and not meet your expectations.
They were ok considering the decline in the last few months ( not when taking the runway ahead into consideration?)
|
|
|
|
Post by mnholdem on Sept 23, 2016 10:29:44 GMT -5
I respectfully disagree with the OP, unless you have proof that MannKind shut its doors for good today? Which, of course, you don't.  |
|
|
|
Post by cjm18 on Sept 23, 2016 10:30:17 GMT -5
Fellow Longs, today marks the day we should all face the facts...MannKind is done. Since August 2015 I believed (& bought; ultimately I've lost -$35k+) Afrezza/Technosphere could improve patients lives and change modern medicine. Unfortunately no amount of good news (the script uptrend, that supposed MLB advertising bullsh*t which will not happen, the stellar ADA+JDRF reviews, etc) can save this company. It is too little to late especially with the staggering & unrelenting short position. Liane can edit & delete posts hiding the scary truth: management squandered a golden opportunity, failed patients and screwed shareholders forever. Only a miracle like Novo Nordisk could save MannKind now and we all know that is not happening. This is a tragic damn shame how this story ended: PWD around the world will never discover the benefits of Afrezza. Big bio-pharma buried disruptive innovation and shorts have won. The only fact in your post is your 35k loss. Mlb advertising won't happen? Okay. The best poker players in the world don't go on tilt when they lose money because they know they still made the right call. And would do it over again. |
|
|
|
Post by trondisc on Sept 23, 2016 10:32:31 GMT -5
did you sell your 100% position today? if so good luck on your next journey. I guess the script growth disappointed you and not meet your expectations. They were ok considering the decline in the last few months ( not when taking the runway ahead into consideration?) Price is truth. Guess you believe we're going to see $1 even $2 again someday. Gut check time. Face reality please, an improving script trend DOES NOT MEAN this company will survive. Even though Afrezza is the best insulin on the market, NO large cap bio-pharma will buy otherwise it would have happened already. |
|
|
|
Post by avichen on Sept 23, 2016 10:36:14 GMT -5
I'm sad indeed. luckily not all my eggs are in this baskets.
But as a diabetic myself. Today had reach all the worst target I've set previously to take loses and let go.
plus annoyed by matt.
there are still those who hold for the hope of getting acquired.
|
|
|
|
Post by trondisc on Sept 23, 2016 10:36:56 GMT -5
I respectfully disagree with the OP, unless you have proof that MannKind shut its doors for good today? Which, of course, you don't. Dude, we're headed for 0.50 even WITH an uptrend in scripts! Don't be complacent (ignorant?) like management. How the hell can you remain positive with a new all-time low and the company on the verge of extinction because of a CEO who seriously lacks leadership!?!? |
|
|
|
Post by mnkdwillwin on Sept 23, 2016 10:39:07 GMT -5
For you and anyothers that sell the game is over. This is not a game. A lot of folks are looking for this to succeed. You obviously have reached your end of the trade. Good luck to you in your future trades.
|
|
|
|
Post by cjm18 on Sept 23, 2016 10:41:29 GMT -5
did you sell your 100% position today? if so good luck on your next journey. I guess the script growth disappointed you and not meet your expectations. They were ok considering the decline in the last few months ( not when taking the runway ahead into consideration?) Price is truth. Guess you believe we're going to see $1 even $2 again someday. Gut check time. Face reality please, an improving script trend DOES NOT MEAN this company will survive. Even though Afrezza is the best insulin on the market, NO large cap bio-pharma will buy otherwise it would have happened already. Kindly remove your head out of your ***. Price is truth? That implies there are never any market inefficiencies. Buyout would have happened already? The drug is worth more now than it was in January when sny ran off with their tail between their legs. Working with jdrf. Titration packs. Mannkind cares. Advertising campaign. Label change application. Scripts were bleeding back then until the launch started. Better (though still needs improvement) insurance coverage. Ada papers. Recent article by novo board member who loves afrezza. |
|
|
|
Post by guidepost on Sept 23, 2016 10:46:21 GMT -5
did you sell your 100% position today? if so good luck on your next journey. I guess the script growth disappointed you and not meet your expectations. They were ok considering the decline in the last few months ( not when taking the runway ahead into consideration?) Price is truth. Guess you believe we're going to see $1 even $2 again someday. Gut check time. Face reality please, an improving script trend DOES NOT MEAN this company will survive. Even though Afrezza is the best insulin on the market, NO large cap bio-pharma will buy otherwise it would have happened already. Kindly remove your head out of your ***. The price is 0.01 lower than the previous low set on 01/06/2016. It did go above $2 after that, and I think it can do the same again. Your tantrums are not helping anyone here. |
|
|
|
Post by trondisc on Sept 23, 2016 10:59:02 GMT -5
Price is truth. Guess you believe we're going to see $1 even $2 again someday. Gut check time. Face reality please, an improving script trend DOES NOT MEAN this company will survive. Even though Afrezza is the best insulin on the market, NO large cap bio-pharma will buy otherwise it would have happened already. Kindly remove your head out of your ***. Price is truth? That implies there are never any market inefficiencies. Buyout would have happened already? The drug is worth more now than it was in January when sny ran off with their tail between their legs. Working with jdrf. Titration packs. Mannkind cares. Advertising campaign. Label change application. Scripts were bleeding back then until the launch started. Better (though still needs improvement) insurance coverage. Ada papers. Recent article by novo board member who loves afrezza. All these "positive" turn of events the last several months you are posting AND YET the price continues to dwindle downward. |
|
|
|
Post by bighaus89 on Sept 23, 2016 10:59:06 GMT -5
Price is truth. Guess you believe we're going to see $1 even $2 again someday. Gut check time. Face reality please, an improving script trend DOES NOT MEAN this company will survive. Even though Afrezza is the best insulin on the market, NO large cap bio-pharma will buy otherwise it would have happened already. Kindly remove your head out of your ***. Price is truth? That implies there are never any market inefficiencies. Buyout would have happened already? The drug is worth more now than it was in January when sny ran off with their tail between their legs. Working with jdrf. Titration packs. Mannkind cares. Advertising campaign. Label change application. Scripts were bleeding back then until the launch started. Better (though still needs improvement) insurance coverage. Ada papers. Recent article by novo board member who loves afrezza. Those are all very good points. I have come to terms a long time ago that I will either make a lot of money on MNKD, or lose my entire investment. |
|
|
|
Post by madman63 on Sept 23, 2016 11:08:37 GMT -5
This thread will go over real well. Sell and move on man. Obviously this is not the risk you were expecting. If you are trying to protect us, no thanks. |
|
|
|
Post by ilovekauai on Sept 23, 2016 11:14:20 GMT -5
Trodisc: I'm sorry you feel so bad about your lost investment, that you feel compelled to trash MNKD and use borderline profanity in personal attacks against posters. Now that you're out, I can only wish you the best in your future investments. If there was an ignore button on this site, you'd be on it with me. Good luck to you wherever life leads. Aloha.
|
|
